Key result
PRSA-BRS correlates moderately with the phenylephrine test but shows marked disagreement in absolute measurements.
Why the study?
Does PRSA-BRS accurately estimate baroreflex sensitivity compared to the phenylephrine method in HF and post-MI patients?
Observational (n=233)
Does PRSA-BRS accurately estimate baroreflex sensitivity compared to the phenylephrine method in HF and post-MI patients?
Despite a moderate correlation, PRSA-BRS shows marked disagreement with the reference phenylephrine method and cannot be used as a direct estimate of baroreflex sensitivity.
Answers are grounded in this paper and cite their sources.
PRSA-BRS should not replace phenylephrine testing in HF or post-MI; leaves open its role as a noninvasive research surrogate.
OBJECTIVES: A novel technique to assess spontaneous baroreflex sensitivity (BRS) by bivariate phase-rectified signal averaging (PRSA-BRS) has been recently proposed and its independent prognostic power demonstrated. This method, however, has never been compared with the phenyleprine test (Phe-BRS), commonly regarded as the reference method in clinical and research applications. APPROACH: In 192 heart failure (HF) and 41 post-myocardial infarction (post-MI) patients we compared PRSA-BRS with Phe-BRS, assessing both association and agreement. MAIN RESULTS: in post-MI patients (p = 0.001). Moderate association was observed (r = 0.53, p < 0.0001 and r = 0.43, p = 0.004 in HF and post-MI, respectively). The vast majority (86% in HF and 90% in post-MI) of PRSA-BRS measurements were smaller than corresponding Phe-BRS values. The difference between PRSA-BRS and Phe-BRS was strongly dependent on the magnitude of BRS, with a trend towards more negative differences as BRS increased. Negative PRSA-BRS values were observed in 15% of HF and in 37% of post-MI patients, whereas negative Phe-BRS values were observed in 8% of HF and 5% of post-MI patients. SIGNIFICANCE: Although the association with Phe-BRS suggests that PRSA-BRS contains relevant information about cardiac autonomic control and reflects the strength of the baroreceptor-heart rate reflex, the marked disagreement between the two measurements indicates that PRSA-BRS measurements cannot be taken as estimates of BRS. Many factors may account for the observed lack of agreement: the different physiological conditions under which Phe-BRS and PRSA-BRS are measured, the inclusion of non-baroreflex mediated components of RR-intervals in PRSA-BRS and some computational aspects related to the normalization of PRSA-BRS values.
No takes yet. Share an insight, caveat, or question.
Maestri et al. (2017) conducted an observational in Heart failure and post-myocardial infarction (n=233). Bivariate phase-rectified signal averaging (PRSA-BRS) vs. Phenylephrine test (Phe-BRS) was evaluated on Association and agreement between PRSA-BRS and Phe-BRS (r = 0.53, p=<0.0001). Bivariate phase-rectified signal averaging (PRSA-BRS) showed moderate correlation with the phenylephrine test but marked disagreement in absolute measurements.
Synapse has enriched 10 related papers. Consider them for comparative context: